Patents by Inventor Daniel David Robinson

Daniel David Robinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110269732
    Abstract: The present invention relates to drug discovery methods, particularly methods for assaying compounds for activity as Aurora kinase inhibitors. This invention also relates to a pharmacophore describing compounds that are able to promote a conformational change in the protein AuroraB and whose binding constant for the two-step process is given as Ki*. Finally, this invention also relates to compounds having the features of the pharmacophore.
    Type: Application
    Filed: October 14, 2009
    Publication date: November 3, 2011
    Applicant: VERTEX PHARMACEUTICALS INCORPORATED
    Inventors: Julian M.C. GOLEC, John POLLARD, James WESTCOTT, Hayley Marie BINCH, Michael Paul MORTIMORE, Daniel David ROBINSON
  • Publication number: 20110060013
    Abstract: The present invention relates to compounds useful as inhibitors of Aurora protein kinases. The invention also provides pharmaceutically acceptable compositions comprising those compounds and methods of using the compounds and compositions in the treatment of various disease, conditions, and disorders. The invention also provides processes for preparing compounds of the invention.
    Type: Application
    Filed: November 20, 2009
    Publication date: March 10, 2011
    Applicant: VERTEX PHARMACEUTICALS INCORPORATED
    Inventors: Michael Paul Mortimore, Christopher John Davis, Julian M.C. Golec, John Studley, Daniel David Robinson
  • Publication number: 20110046104
    Abstract: The present invention relates to compounds useful as inhibitors of Aurora protein kinases. The invention also provides pharmaceutically acceptable compositions comprising those compounds and methods of using the compounds and compositions in the treatment of various disease, conditions, and disorders. The invention also provides processes for preparing compounds of the invention.
    Type: Application
    Filed: October 30, 2009
    Publication date: February 24, 2011
    Applicant: VERTEX PHARMACEUTICALS INCORPORATED
    Inventors: Michael Paul Mortimore, Julian M.C. Golec, Daniel David Robinson, John Studley
  • Publication number: 20100215772
    Abstract: The present invention relates to compounds useful as inhibitors of Aurora protein kinases. The invention also provides pharmaceutically acceptable compositions comprising those compounds and methods of using the compounds and compositions in the treatment of various disease, conditions, and disorders. The invention also provides processes for preparing compounds of the invention.
    Type: Application
    Filed: October 30, 2009
    Publication date: August 26, 2010
    Applicant: VERTEX PHARMACEUTICALS INCORPORATED
    Inventors: Michael Mortimore, Julian M.C. Golec, Daniel David Robinson, John Studley